Peggy M Cawthon1,2, Terri Blackwell1, Steven R Cummings1,2, Eric S Orwoll3, Kate A Duchowny2, Deborah M Kado4,5, Katie L Stone1, Kristine E Ensrud6,7, Jane A Cauley8, William J Evans9,10. 1. Research Institute, California Pacific Medical Center, San Francisco. 2. Department of Epidemiology and Biostatistics, University of California, San Francisco. 3. Department of Medicine, Oregon Health and Science University, Portland. 4. Department of Family Medicine and Public Health, University of California, San Diego. 5. Department of Internal Medicine, University of California, San Diego. 6. Center for Chronic Disease Outcomes Research, Minneapolis VA Health Care System, Minnesota. 7. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis. 8. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania. 9. Department of Nutrition Sciences, University of California, Berkeley. 10. Department of Medicine, Duke University, Durham, North Carolina.
Abstract
BACKGROUND: Whether low muscle mass is a risk factor for disability and mortality is unclear. Associations between approximations of muscle mass (including lean mass from dual-energy x-ray absorptiometry [DXA]), and these outcomes are inconsistent. METHODS: Muscle mass measured by deuterated creatine (D3Cr) dilution and appendicular lean mass (ALM, by DXA) were assessed at the Year 14 Visit (2014-2016) of the prospective Osteoporotic Fractures in Men study (N = 1,425, age 77-101 years). Disability in activities of daily living (ADLs), instrumental ADLs, and mobility tasks was self-reported at the Year 14 visit and 2.2 years later; deaths were centrally adjudicated over 3.3 years. Relative risks and 95% confidence intervals (CI) were estimated per standard deviation decrement with negative binomial, logistic regression, or proportional hazards models. RESULTS: In age- and clinical center-adjusted models, the relative risks per decrement in D3Cr muscle mass/wgt was 1.9 (95% CI: 1.2, 3.1) for incident self-reported ADL disability; 1.5 (95% CI: 1.3, 1.9) for instrumental ADL disability; and 1.8 (95% CI: 1.5, 2.2) for mobility disability. In age-, clinical center-, and weight-adjusted models, the relative risks per decrement in D3Cr muscle mass was 1.8 (95% CI: 1.5, 2.2) for all-cause mortality. In contrast, lower DXA ALM was not associated with any outcome. Associations of D3Cr muscle mass with these outcomes were slightly attenuated after adjustment for confounding factors and the potentially mediating effects of strength and physical performance. CONCLUSIONS: Low muscle mass as measured by D3Cr dilution is a novel risk factor for clinically meaningful outcomes in older men.
BACKGROUND: Whether low muscle mass is a risk factor for disability and mortality is unclear. Associations between approximations of muscle mass (including lean mass from dual-energy x-ray absorptiometry [DXA]), and these outcomes are inconsistent. METHODS: Muscle mass measured by deuterated creatine (D3Cr) dilution and appendicular lean mass (ALM, by DXA) were assessed at the Year 14 Visit (2014-2016) of the prospective Osteoporotic Fractures in Men study (N = 1,425, age 77-101 years). Disability in activities of daily living (ADLs), instrumental ADLs, and mobility tasks was self-reported at the Year 14 visit and 2.2 years later; deaths were centrally adjudicated over 3.3 years. Relative risks and 95% confidence intervals (CI) were estimated per standard deviation decrement with negative binomial, logistic regression, or proportional hazards models. RESULTS: In age- and clinical center-adjusted models, the relative risks per decrement in D3Cr muscle mass/wgt was 1.9 (95% CI: 1.2, 3.1) for incident self-reported ADL disability; 1.5 (95% CI: 1.3, 1.9) for instrumental ADL disability; and 1.8 (95% CI: 1.5, 2.2) for mobility disability. In age-, clinical center-, and weight-adjusted models, the relative risks per decrement in D3Cr muscle mass was 1.8 (95% CI: 1.5, 2.2) for all-cause mortality. In contrast, lower DXA ALM was not associated with any outcome. Associations of D3Cr muscle mass with these outcomes were slightly attenuated after adjustment for confounding factors and the potentially mediating effects of strength and physical performance. CONCLUSIONS: Low muscle mass as measured by D3Cr dilution is a novel risk factor for clinically meaningful outcomes in older men.
Authors: Richard V Clark; Ann C Walker; Robin L O'Connor-Semmes; Michael S Leonard; Ram R Miller; Stephen A Stimpson; Scott M Turner; Eric Ravussin; William T Cefalu; Marc K Hellerstein; William J Evans Journal: J Appl Physiol (1985) Date: 2014-04-24
Authors: E Dent; J E Morley; A J Cruz-Jentoft; H Arai; S B Kritchevsky; J Guralnik; J M Bauer; M Pahor; B C Clark; M Cesari; J Ruiz; C C Sieber; M Aubertin-Leheudre; D L Waters; R Visvanathan; F Landi; D T Villareal; R Fielding; C W Won; O Theou; F C Martin; B Dong; J Woo; L Flicker; L Ferrucci; R A Merchant; L Cao; T Cederholm; S M L Ribeiro; L Rodríguez-Mañas; S D Anker; J Lundy; L M Gutiérrez Robledo; I Bautmans; I Aprahamian; J M G A Schols; M Izquierdo; B Vellas Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Anne B Newman; Varant Kupelian; Marjolein Visser; Eleanor Simonsick; Bret Goodpaster; Michael Nevitt; Stephen B Kritchevsky; Frances A Tylavsky; Susan M Rubin; Tamara B Harris Journal: J Am Geriatr Soc Date: 2003-11 Impact factor: 5.562
Authors: Stephen B Kritchevsky; Kristen M Beavers; Michael E Miller; M Kyla Shea; Denise K Houston; Dalane W Kitzman; Barbara J Nicklas Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240
Authors: Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni Journal: Age Ageing Date: 2019-01-01 Impact factor: 10.668
Authors: Lorenzo M Donini; Luca Busetto; Stephan C Bischoff; Tommy Cederholm; Maria D Ballesteros-Pomar; John A Batsis; Juergen M Bauer; Yves Boirie; Alfonso J Cruz-Jentoft; Dror Dicker; Stefano Frara; Gema Frühbeck; Laurence Genton; Yftach Gepner; Andrea Giustina; Maria Cristina Gonzalez; Ho-Seong Han; Steven B Heymsfield; Takashi Higashiguchi; Alessandro Laviano; Andrea Lenzi; Ibolya Nyulasi; Edda Parrinello; Eleonora Poggiogalle; Carla M Prado; Javier Salvador; Yves Rolland; Ferruccio Santini; Mireille J Serlie; Hanping Shi; Cornel C Sieber; Mario Siervo; Roberto Vettor; Dennis T Villareal; Dorothee Volkert; Jianchun Yu; Mauro Zamboni; Rocco Barazzoni Journal: Obes Facts Date: 2022-02-23 Impact factor: 4.807
Authors: Peggy M Cawthon; Katherine E Peters; Steven R Cummings; Eric S Orwoll; Andrew R Hoffman; Kristine E Ensrud; Jane A Cauley; William J Evans Journal: J Bone Miner Res Date: 2022-03-06 Impact factor: 6.390
Authors: James S Andrews; Laura S Gold; May J Reed; Jose M Garcia; Robyn L McClelland; Annette L Fitzpatrick; Catherine L Hough; Peggy M Cawthon; Ken E Covinsky Journal: J Gerontol A Biol Sci Med Sci Date: 2022-07-05 Impact factor: 6.591
Authors: Samaneh Farsijani; Lingshu Xue; Robert M Boudreau; Adam J Santanasto; Stephen B Kritchevsky; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2021-11-15 Impact factor: 6.053
Authors: Jesse Zanker; Terri Blackwell; Sheena Patel; Kate Duchowny; Sharon Brennan-Olsen; Steven R Cummings; William J Evans; Eric S Orwoll; David Scott; Sara Vogrin; Gustavo Duque; Peggy M Cawthon Journal: Exp Gerontol Date: 2022-01-29 Impact factor: 4.032
Authors: Eric S Orwoll; Terri Blackwell; Steven R Cummings; Jane A Cauley; Nancy E Lane; Andrew R Hoffman; Andrew J Burghardt; William J Evans; Peggy M Cawthon Journal: J Gerontol A Biol Sci Med Sci Date: 2022-04-01 Impact factor: 6.591
Authors: Kexin Zhu; Jean Wactawski-Wende; Heather M Ochs-Balcom; Michael J LaMonte; Kathleen M Hovey; William Evans; Mahalakshmi Shankaran; Bruce R Troen; Hailey R Banack Journal: J Gerontol A Biol Sci Med Sci Date: 2021-08-13 Impact factor: 6.053